RFA R-Evolution: a New Protocol to Avoid Implant Failure
ConditionDental Implants
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDaniele Moretto
About this trial
The main objective of this study is to assess the impact of confounding factors such as jaw, implant position, indication, smoking status, implant dimension, and medical history on RFA trends. In addition, this study aims to explore correlations of RFA trend, with the goal of using ISQ trends as an indicator for treatment protocol decisions (e.g. time of loading). Participants have already received dental implant as per clinic's standard protocol. Information regarding Implant Stability Quotient (ISQ) measurements performed at any time point until 1-year follow-up will be collected. The principal investigator protocol regarding the use of ISQ measure to define time of implant loading will also be assessed. Only participants followed up at least until one year after implant placement will be included in the data collection.
Eligibility criteria
Qualifiers
Participant received implant treatment NobelReplace, NobelActive or NobelParallel implants on or after October 2021 (with TiUnite or TiUltra surfaces)
Participant was at least 18 years old at the time of surgery
Participant attended a follow-up visit at least 1-year after surgery
Implant stability was assessed by means of RFA at a minimum of three time-points
Disqualifiers
1-year follow-up data not available
Subject received major guided bone regeneration
Trial design
Treatments tested in this trial
- Dental implant
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Daniele Moretto
Lead sponsor
Odontoiatri Associati, Bologna
Sponsor institution
Source ClinicalTrials.gov